Instituto Biológico Contemporáneo S.A. (IBC) is an Argentine-owned company dedicated exclusively to the production of injectable medical specialties, for both the national and the international pharmaceutical industry.
Since its establishment in the Autonomous City of Buenos Aires in 1989, IBC has developed a policy based on growth and continuous improvement. A milestone on its trajectory is the launch of the PHARMAVIAL line, initiating a new impulse of growth and expansion.
From its beginnings, IBC has had a constant vocation to provide quality excellence in all its pharmaceutical services. This is supported by a highly trained team of professionals, modern facilities, and state-of-the-art technology. Our structure guarantees the compliance with the strict standards of GMP (Good Manufacture Practices) and GLP (Good Laboratory Practices), that govern the pharmaceutical industry.
Apart from the local certifications of ANMAT, we are also certified by MERCOSUR and INVIMA (Colombia), which has allowed IBC to gain access to the international market in Latin America and Asia, since 2018.
Our development team works on the creation of new products and the expansion of the portfolio, with the strong determination of evolving and growing constantly.